Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal CancerRona Yaeger, Daisuke Kotani, Sebastián Mondaca, et al.
Nature|June 25, 2016
A combinatorial strategy for treating KRAS-mutant lung cancerEusebio Manchado, Susann Weissmueller, John P Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2024
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain MutationsEranga R Balasooriya, Qibiao Wu, Haley Ellis, et al.
Molecular Cell|August 18, 2022
Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progressionIoannis Sanidas, Hanjun Lee, Purva H Rumde, et al.
The Journal of Clinical Investigation|January 22, 2026
ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription ReprogrammingParasvi S Patel, Jacob P Matson, Xiaojuan Ran, et al.
Cancer Discovery|January 18, 2024
Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C CancersDouglas A Rubinson, Noritaka Tanaka, Ferran Fece de la Cruz, et al.
Blood|April 4, 2002
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacyWyndham H Wilson, Michael L Grossbard, Stefania Pittaluga, et al.
Oncoimmunology|May 4, 2018
A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanomaMeghan J Mooradian, Alexandre Reuben, Peter A Prieto, et al.
JCO Precision Oncology|October 12, 2023
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA TestingStefania Napolitano, Aparna R Parikh, Jason Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2019
Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal CancerSophia C Kamran, Jochen K Lennerz, Claire A Margolis, et al.
Pageof 16